After benefiting from record COVID-19 testing revenue over 2020-21 (and most of 2022), the expected tapering of the pandemic tailwinds has weighed on the stock over the last year. However, with the unwinding of the tailwinds coming to an end, and the core business performance remaining resilient, we believe it is worth taking a closer look at this TIC (Testing, Inspection and Certification) player.
